logo
Select company
Select metric
$ 18.2MNet Cash Flow - Investment Acquisitions and Disposals
VS
Market
84
Sector
79
Industry
74
History
92
$ 2.31Close
$ 1.11 - $ 4.65 52-Week Range
Ticker Information

Ticker

SABS

Company Name

SAB BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SAB BIOTHERAPEUTICS INC - Net Cash Flow - Investment Acquisitions and Disposals Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SABS - CF - Investments Historical data
DateNet Cash Flow - Investment Acquisitions and Disposals
6/30/2025$ 18.2M
3/31/2025$ 24.28M
12/31/2024$ -11.63M
9/30/2024$ -21.01M
6/30/2024$ -19.96M
3/31/2024$ -31.23M
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SAB BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) CF - Investments stands at $ 0.
  • Over the past 5 years, SAB BIOTHERAPEUTICS INC's average CF - Investments has been $ -2.95M.
  • The median CF - Investments for SAB BIOTHERAPEUTICS INC during this period was $ 0
  • SAB BIOTHERAPEUTICS INC reached its highest CF - Investments over the past 5 years at $ 24.28M.
  • The lowest CF - Investments recorded by SAB BIOTHERAPEUTICS INC in the same timeframe $ -31.23M

SAB BIOTHERAPEUTICS INC's CF - Investments vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Investments Benchmarks
CompanyCF - Investments
ABP : ABPRO HOLDINGS INC $ 0AIM : AIM IMMUNOTECH INC $ 6.25MAIMD : AINOS INC $ 5.55KPFSA : PROFUSA INC $ -2.62MKAPA : KAIROS PHARMA LTD $ 0PPCB : PROPANC BIOPHARMA INC $ 0QTTB : Q32 BIO INC $ 10MCVKD : CADRENAL THERAPEUTICS INC $ 0VIVS : VIVOSIM LABS INC $ 18KLIXT : LIXTE BIOTECHNOLOGY HOLDINGS INC $ 345.75K

Definition of Net Cash Flow - Investment Acquisitions and Disposals

[Cash Flow Statement] A component of cash flow from investing [NCFI], representing the cash inflow (outflow) from disposal (acquisition) of investments. Includes marketable securities and loan originations.

SABS - Net Cash Flow - Investment Acquisitions and Disposals, Last 5 years

$ -31.23M

Minimum

Mar 31, 2024

$ 24.28M

Maximum

Mar 31, 2025

$ -2.95M

Average

$ 0

Median

CF - Investments Benchmark Analysis

The chart above depicts the distribution of CF - Investments for companies in the Total Stock Market. The average CF - Investments of the companies is $ 47.99K with a standard deviation of $ 2.28M.
The following table provides additional summary stats:
CF - Investments in the Market:
filtered constituents2.5K
min$ -9.71M
max$ 9.79M
average$ 47.99K
median$ 0
std$ 2.28M